Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 5—May 2025
Research
Detection of SARS-CoV-2 Reinfections Using Nucleocapsid Antibody Boosting
Table 2
Reinfection classification data determined from ratio approach in study of SARS-CoV-2 reinfections detected by nucleocapsid antibody boosting*
Cases |
Controls |
Unweighted Youden's J (1.43) |
Weighted Youden's J (2.33) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
S/CO | No. | Median ratio | No. | Median ratio | Sensitivity, % | Specificity, % | Sensitivity, % | Specificity, % | |||
Overall | 2,681 | 6.22 | 5,150 | 0.55 | 87.1 | 96.0 | 75.3 | 99.3 | |||
0–50 | 1,661 | 15.2 | 2,237 | 0.49 | 93.8 | 97.0 | 91.6 | 98.9 | |||
50–100 | 485 | 3.41 | 1,042 | 0.49 | 89.5 | 97.3 | 81.9 | 99.2 | |||
100–150 | 275 | 2.15 | 757 | 0.56 | 88.0 | 91.7 | 35.6 | 99.9 | |||
>150 | 260 | 1.28 | 1,114 | 0.76 | 38.8 | 95.5 | 0.8 | 100.0 |
*S/CO value is prereinfection. Unweighted and weighted boosting thresholds are ratios of postreinfection to prereinfection S/CO. S/CO, signal-to-cutoff ratio.
1These senior authors contributed equally to this article.
Page created: March 25, 2025
Page updated: April 22, 2025
Page reviewed: April 22, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.